Director Raquel C. Bono filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on October 20, 2026, reporting no securities beneficially owned in Vaxart, Inc. (NASDAQ:VXRT) as of the event date of October 16, 2026.

Key Highlights

  • Reporting person: Raquel C. Bono, identified as a Director of Vaxart, Inc.
  • Event date: October 16, 2026, triggering the initial ownership statement requirement.
  • No securities owned: The filing states "No securities are beneficially owned" in both the non-derivative and derivative securities tables.
  • Filing date: The form was filed on October 20, 2026, signed by Edward Berg as Attorney-in-Fact for Raquel C. Bono.
  • Filing type: This is an initial statement, not an amendment, filed by one reporting person.

Bono Reports Zero Beneficial Ownership Upon Joining Vaxart Board

According to the filing, Raquel C. Bono submitted a Form 3 to the SEC on October 20, 2026, with an event date of October 16, 2026. The filing identifies Bono solely as a Director of Vaxart, Inc., whose address is listed as 310 Utah Avenue, Suite 150, South San Francisco, California 94080. The form was filed by one reporting person and is not an amendment to a prior filing.

Both Table I, covering non-derivative securities, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, are blank. The filing includes an explicit remark stating "No securities are beneficially owned," indicating that Bono held no direct or indirect beneficial ownership of Vaxart securities as of the event date. The form was signed by Edward Berg as Attorney-in-Fact for Raquel C. Bono, with a power of attorney referenced as Exhibit 24.

Form 3 is required under Section 16(a) of the Securities Exchange Act of 1934 for individuals who become directors, officers, or ten-percent owners of a registered issuer. The filing reflects Bono's initial ownership position at the time she became subject to Section 16 reporting obligations, as disclosed in the document.

What Was Disclosed

Vaxart, Inc. Director Raquel C. Bono filed an initial beneficial ownership statement reporting no securities held, either directly or indirectly, in non-derivative or derivative form, as of October 16, 2026.